ARHGEF3 and neoplasm: These findings underscore a potentially important role of ARHGEF3 in the development and progression of NPC, and suggest that examination of ARHGEF3 expression by IHC could be used as an additional tool in identifying those NPC patients at increased risk of tumor growth and/or metastasis.